FI925590A0 - Expression av specifika immunogener genom anvaendning av virusantigener - Google Patents

Expression av specifika immunogener genom anvaendning av virusantigener

Info

Publication number
FI925590A0
FI925590A0 FI925590A FI925590A FI925590A0 FI 925590 A0 FI925590 A0 FI 925590A0 FI 925590 A FI925590 A FI 925590A FI 925590 A FI925590 A FI 925590A FI 925590 A0 FI925590 A0 FI 925590A0
Authority
FI
Finland
Prior art keywords
virusantigener
specifika
immunogener
expression
anvaendning
Prior art date
Application number
FI925590A
Other languages
English (en)
Other versions
FI925590A (fi
Inventor
Paul Porwen Hung
Shaw-Guang Lin Lee
Narender Kumar Kalyan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI925590A0 publication Critical patent/FI925590A0/fi
Publication of FI925590A publication Critical patent/FI925590A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI925590A 1991-12-11 1992-12-09 Expression av specifika immunogener genom anvaendning av virusantigener FI925590A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80510591A 1991-12-11 1991-12-11

Publications (2)

Publication Number Publication Date
FI925590A0 true FI925590A0 (fi) 1992-12-09
FI925590A FI925590A (fi) 1993-06-12

Family

ID=25190685

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925590A FI925590A (fi) 1991-12-11 1992-12-09 Expression av specifika immunogener genom anvaendning av virusantigener

Country Status (17)

Country Link
US (1) US5591823A (fi)
EP (1) EP0546787A3 (fi)
JP (1) JPH05262667A (fi)
KR (1) KR930013112A (fi)
CN (1) CN1073878A (fi)
AU (1) AU2981992A (fi)
BR (1) BR9204978A (fi)
CA (1) CA2084180A1 (fi)
CZ (1) CZ362692A3 (fi)
FI (1) FI925590A (fi)
HU (2) HUT65366A (fi)
IL (1) IL103928A0 (fi)
MX (1) MX9207113A (fi)
NO (1) NO924780L (fi)
SK (1) SK362692A3 (fi)
TW (1) TW239162B (fi)
ZA (1) ZA929355B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633929B1 (en) * 1992-04-01 2004-03-03 The Rockefeller University METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS
EP0671926B1 (en) * 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
WO1995007099A1 (fr) * 1993-09-09 1995-03-16 The Nisshin Oil Mills, Ltd. Vaccin et procede pour sa production
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
ES2370937T3 (es) 1993-09-13 2011-12-23 Protein Sciences Corporation Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
US6300090B1 (en) 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
DE69535716T2 (de) * 1995-05-26 2009-03-19 Protein Sciences Corp., Meriden Methode für die Produktion von multivalenten Influenza Hämagglutinin Vakzinen
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
AU7471098A (en) * 1997-04-30 1998-11-24 Mount Sinai School Of Medicine Of The City University Of New York, The Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
US6274378B1 (en) 1997-10-27 2001-08-14 The Rockefeller University Methods and compositions for obtaining mature dendritic cells
AU2872199A (en) 1998-02-20 1999-09-06 Rockefeller University, The Apoptotic cell-mediated antigen presentation to dendritic cells
AU2002223398A1 (en) * 2000-08-10 2002-04-08 Tsinghua University A vaccine for influenza virus and its preparation
JP2004508977A (ja) 2000-09-11 2004-03-25 ダウ　グローバル　テクノロジーズ　インコーポレイティド ランフラットタイヤ支持体
WO2004091491A2 (en) * 2003-04-10 2004-10-28 Transform Pharmaceuticals, Inc. Profiling conformational variants, antibody compositions and methods of using the same
CA2610667A1 (en) * 2005-06-01 2006-12-07 Variation Biotechnologies Inc. Peptide-based influenza vaccine formulation
WO2007084568A2 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
AU2008293504B2 (en) * 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
KR101705150B1 (ko) 2008-10-22 2017-02-22 온코세라피 사이언스 가부시키가이샤 Ｒａｂ６ｋｉｆｌ／ｋｉｆ２０ａ 에피토프 펩티드 및 이를 포함하는 백신
CN101708442B (zh) * 2009-09-04 2011-08-24 山东中惠仪器有限公司 全自动标准气体配制装置
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10063211B2 (en) * 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2022108149A (ru) * 2016-02-03 2022-05-05 СиДжи ДИСКАВЕРИ, ИНК. Композиции гемагглютинина гриппа с гетерологичными эпитопами и/или измененными сайтами расщепления при созревании

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
EP0492920A1 (en) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimaeric influenza-HIV vaccine

Also Published As

Publication number Publication date
NO924780D0 (no) 1992-12-10
TW239162B (fi) 1995-01-21
AU2981992A (en) 1993-06-17
US5591823A (en) 1997-01-07
FI925590A (fi) 1993-06-12
HU9203931D0 (en) 1993-04-28
CZ362692A3 (en) 1994-02-16
EP0546787A2 (en) 1993-06-16
EP0546787A3 (en) 1994-06-01
HUT65366A (en) 1994-05-02
ZA929355B (en) 1994-06-02
NO924780L (no) 1993-06-14
MX9207113A (es) 1994-05-31
BR9204978A (pt) 1993-06-15
SK362692A3 (en) 1995-11-08
KR930013112A (ko) 1993-07-21
JPH05262667A (ja) 1993-10-12
HU211548A9 (en) 1995-12-28
IL103928A0 (en) 1993-04-04
CA2084180A1 (en) 1993-06-12
CN1073878A (zh) 1993-07-07

Similar Documents

Publication Publication Date Title
FI925590A0 (fi) Expression av specifika immunogener genom anvaendning av virusantigener
FI933982A (fi) Framstaellning av dieselbraensle genom hydrering av ett dieselmatningsmaterial
FI921369A (fi) Anvaendarfoerbindelse foer kontrollsystem av anlaeggningskomponenter
FI921599A (fi) Kodingsfoerfarande och -anordning foer foerutsaegning av roerelsekompensation
FI931487A0 (fi) Foerfarande foer framstaellning av myrsyra genom termisk soenderdelning avkvaternaera ammoniumformiat
FI921299A (fi) Laongspaltpress saerskilt foer avvattning av en fiberaemnesbana
FI945397A0 (fi) Foerbaettrad syrsaettning av talloljetvaol genom anvaendning av koldioxid
FI921290A (fi) Skenlaeggningsmaskin foer kontrollerad nedsaenkning av en skena
FI921149A (fi) Reaktivering av hydroformyleringskatalysatorer
FI921202A (fi) Foerfarande foer instaellning av rasterpunktstorleken foer en offset-rotationstryckmaskin
FI920993A (fi) Foerfarande foer framstaellning av galliumfoereningar
FI921037A (fi) Vaermesensor av kompensationstyp
FI921721A (fi) Foerfarande foer isynnerhet foersnabbad aerobisk mikrobiologisk nedbrytning av biologiska aemnen
FI921458A (fi) Hjaelpmedel foer svetsning av ytterst korrosionsbestaendiga austenitiska staol
FI88701B (fi) Foerfarande foer producering av vaeteperoxid
FI914586A (fi) Foerfarande foer foerminskning av asklasten av en cellufabriks pannanlaeggning
FI921103A (fi) Foerfarande foer framstaellning av oxamid
FI921404A (fi) Foerfarande foer framstaellning av elektrolumisescens tunnfolie
FI920422A (fi) Foerfarande foer ytfoerening av kiselhalvledarskivor
FI912871A (fi) Foerfarande foer boejning av glasskivor
FI920926A (fi) Foerfarande foer foerbaettring av stabiliteten foer hoegalkaliska proteaser
FI88635C (fi) Anordning foer fraesning av jord
FI920823A (fi) Foerfarande foer framstaellning av fettsyrahalogenid
FI921744A (fi) Foerfarande foer framstaellning av lineaer viskoelastisk vatten haltig flytande detergentkomposition foer automatiska diskmaskiner
FI914597A (fi) Foerfarande foer framstaellning av goedselmaterial

Legal Events

Date Code Title Description
FD Application lapsed